Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer

Clinical trial NCT02649855 · COMPLETED

Trial details

NCT number: NCT02649855
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Neoplasms Neoplasms, Prostatic

Start date: 2016-01-19
Primary completion: 2022-07-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.